Detalhe da pesquisa
1.
Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: a 12-year longitudinal follow-up study and comparison with the general female population.
Acta Oncol
; 62(7): 719-727, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534752
2.
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Br J Cancer
; 125(3): 380-389, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035435
3.
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery.
Br J Nutr
; 125(2): 172-182, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811572
4.
Pneumonitis and fibrosis after breast cancer radiotherapy: occurrence and treatment-related predictors.
Acta Oncol
; 60(12): 1651-1658, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618657
5.
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
Int J Cancer
; 147(9): 2515-2525, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488909
6.
Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.
MAGMA
; 33(2): 317-328, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562584
7.
Correction to: Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.
MAGMA
; 33(2): 329-330, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664580
8.
Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer.
Acta Radiol
; 61(7): 875-884, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31744303
9.
Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients.
J Proteome Res
; 18(10): 3649-3660, 2019 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483662
10.
Diversity in changes of HRQoL over a 1-year period after radiotherapy in Norwegian breast cancer patients: results of cluster analyses.
Qual Life Res
; 28(6): 1521-1530, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729449
11.
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.
Br J Cancer
; 119(9): 1144-1154, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30401977
12.
Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
NMR Biomed
; 27(8): 887-96, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24840393
13.
Metabolic characterization of triple negative breast cancer.
BMC Cancer
; 14: 941, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25495193
14.
Pulmonary Function and Lung Fibrosis up to 12 Years After Breast Cancer Radiotherapy.
Int J Radiat Oncol Biol Phys
; 118(4): 1066-1077, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099884
15.
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.
Breast Cancer Res Treat
; 141(2): 243-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996142
16.
One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients--comparison to general population.
Acta Oncol
; 52(2): 239-48, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23210971
17.
Metabolic profiles of brain metastases.
Int J Mol Sci
; 14(1): 2104-18, 2013 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23340650
18.
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Genome Med
; 15(1): 104, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053165
19.
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.
JCO Precis Oncol
; 7: e2300338, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039432
20.
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Breast Cancer Res
; 14(2): R47, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22420423